s6y
Company name or ticker
Search
Enliven Therapeutics, Inc.
4
Collins Helen Louise: Statement of changes in beneficial ownership of securities
Filed
Wednesday, October 21, 2026
Period
Oct 19, 2026
Accession number
0001701247-26-000014
Documents
form4-10212026_091032.xml
4
On sec.gov
Filing index
All files
Complete submission text
SGML header